Both in Pharmaceuticals
Merck & Co. vs Vertex Pharmaceuticals
Over the past year MRK returned +81.3% and VRTX returned +31.2%; their daily moves had a correlation of 0.42.
MRK +81.3% VRTX +31.2%Growth of $1, one year, split-adjusted
| Metric | MRK | VRTX |
|---|---|---|
| Price | $149.52 | $558.88 |
| Market cap | $368.89B | $141.65B |
| Today | +2.18% | +3.50% |
| 1 month | +4.0% | +10.3% |
| 6 months | +33.3% | +31.8% |
| Year to date | +42.0% | +23.3% |
| 1 year | +72.7% | +34.0% |
| Revenue growth (YoY) | +5.1% | +12.5% |
| Gross margin | 73.5% | 85.3% |
| Net margin | −8.0% | 33.0% |
| P/E (TTM) | 116.3× | 32.2× |
| Price / sales | 5.5× | 11.3× |
| Net cash | -$46.77B | $7.85B |
| Dividend yield | 2.27% | — |
| Volatility (60d) | 36.0% | 28.7% |
| Short % of float | 1.1% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).